Diabetes Qatar (DQ) has launched its annual campaign to mark World Diabetes Day, an international event observed each year on 14 November. The campaign features a public walkathon and a scientific conference aimed at raising awareness and improving care for the condition.
This year’s campaign focuses on the daily challenges faced by employees living with diabetes and highlights the crucial role of supportive workplaces and employers in managing the condition effectively.
Rising Global Diabetes Cases
Dr Abdulla al-Hamaq, executive director of Diabetes Qatar, stressed the urgency of the issue, citing data from the International Diabetes Federation (IDF). “The facts and figures of diabetes show the escalating global burden on people and countries,” he said.
According to the IDF, approximately 537 million adults aged 20-79 are currently living with diabetes. Projections indicate this number will rise by 46% to 783 million by 2045, underscoring the growing health threat posed by the disease. World Diabetes Day was established in 1991 by the IDF and the World Health Organisation to address these concerns.
Key Campaign Events in Qatar
As part of its awareness drive, Diabetes Qatar has organised two major events for the public and healthcare professionals.
Diabetes Walkathon at Aspire Park
A “Diabetes Walkathon” will take place on 14 November at Aspire Park. The event has historically attracted a wide range of participants, including decision-makers, health leaders, and students. Dr al-Hamaq has extended an open invitation, calling on government agencies, civil society institutions, schools, and the general public to register and participate.
Annual Scientific Conference
DQ will also host its annual scientific conference from 21-22 November at the Qatar National Convention Centre, a popular venue for major events like the upcoming Qatar Investment & Innovation Conference. This year’s conference is held under the theme “Diabetes and Well-Being: A Holistic Approach to Health”.
The event will bring together diabetologists, endocrinologists, general practitioners, cardiologists, and dieticians. Sessions will cover new policies for diabetes control, innovative approaches to managing complications, the latest research on diabetes in children, and advancements in insulin and pump therapies. The primary focus will be on advancements in treatment, technology integration, and strategies for prevention and lifestyle improvement.
